Israel Active

During 2022 Magen David Adom EMTs and paramedics attended over 1.3 million emergencies from nearly 200 stations. The call centers received on average one call every 10.8 seconds. MDA’s 31,600 staff include nearly 14,600 youth volunteers.

  The maximum prices for dispensed medicines in Israel are to fall by an average of nearly 7.5%. Israel’s prescription prices are based on the lowest that the medicines cost in Europe on Jan 1st. Israelis then only pay 15% of that price – the remainder being paid by Israel’s health companies.

This article identifies three more Israeli companies that are expected to receive FDA approval for treatments in 2023. They are Gamida Cell (Omidubicel / NiCord – bone marrow transplants); Protalix (PRX-102 – Fabry disease); and BioLineRX (BL-8040 / Motixafortide – multiple myeloma).

Israel’s Mediwound has received FDA approval for its NexoBrid pineapple plant-based burn treatment (see previously) to be sold in the US to treat thermal burns. The US already has emergency stockpiles. NexoBrid is now approved for use in 44 countries, including the EU, Japan, and India.

Thanks to the Fertility Preservation Center at Sheba Medical Center, Ayelet, 35, gave birth to her fourth child, following years of aggressive cancer treatment for Hodgkin lymphoma. She is the first woman in the world to give birth to 4 children through cryopreservation of her eggs.

Doctors at Jerusalem’s Hadassah hospital removed a blood clot in an Israeli’s lung (pulmonary embolism) using, for the first time in Israel, a US-developed FlowTriever. It sucked out some of the patient’s blood, cleaned it of the clot and replaced it. No blood thinners, no invasive surgery.

Essential tremor usually affects hands and arms on both sides of the body – one side more than the other. Israel’s Insightec (see previously) has now received FDA approval to treat the second side of the brains of patients in the US a minimum of nine months after treatment of the first side.

2,500+ US physicians have prescribed the Nerivio migraine relief device from Israel’s Theranica, benefiting some 35,000 Americans with its neuromodulation technology.

Israel’s Magdent (see previously) has received CE approval for its Miniaturized Electromagnetic Device (MED) that has been clinically proven to shorten the healing process after dental implants by up to 3 times. The device is being sold in Israel and the EU. FDA approval is being sought.

Israelis have the world’s 10th highest life expectancy, according to the Worldometer’s Life Expectancy of the World Population - a project by NiceR that helps Americans access affordable prescription medications. The average Israeli life expectancy is 83.5 (82 for men and 85 for women). In 2020 it was 82.6